Affymetrix Hits GAAP Profitability for FY 03

Jan 28, 2004

NEW YORK, Jan. 28 (GenomeWeb News) - Affymetrix today reported total revenues of $300 million for fiscal year 2003 and marked its first year of positive cash flow from operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Hearst Invests $75M in M2Gen
BD, Euroclone Sign Development, Distribution Agreement for STD Detection Tests
Optalysys Raises $4M in Seed Funding Round
RNA-Editing Protein ADAR Promotes Progression of Lung Cancer, New Study Finds
Biognosys, Waters Ink Comarketing Deal for DIA Mass Spec Tech
Researchers Identify SNP Set, Develop QR Code to Distinguish Genome Samples

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Main menu